Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NYSE - Delayed Quote USD

Avantor, Inc. (AVTR)

Compare
16.18
+0.01
+(0.06%)
At close: March 28 at 4:00:02 PM EDT
16.40
+0.22
+(1.36%)
Pre-Market: 5:43:30 AM EDT
Loading Chart for AVTR
  • Previous Close 16.17
  • Open 16.15
  • Bid 15.00 x 3000
  • Ask 16.46 x 1800
  • Day's Range 16.00 - 16.23
  • 52 Week Range 15.37 - 28.00
  • Volume 4,997,426
  • Avg. Volume 6,622,644
  • Market Cap (intraday) 11.017B
  • Beta (5Y Monthly) 1.30
  • PE Ratio (TTM) 15.56
  • EPS (TTM) 1.04
  • Earnings Date Apr 25, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 24.48

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

www.avantorsciences.com

13,500

Full Time Employees

December 31

Fiscal Year Ends

Recent News: AVTR

View More

Performance Overview: AVTR

Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

AVTR
23.21%
S&P 500 (^GSPC)
5.11%

1-Year Return

AVTR
36.72%
S&P 500 (^GSPC)
6.22%

3-Year Return

AVTR
52.68%
S&P 500 (^GSPC)
21.97%

5-Year Return

AVTR
39.48%
S&P 500 (^GSPC)
119.59%

Compare To: AVTR

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AVTR

View More

Valuation Measures

Annual
As of 3/28/2025
  • Market Cap

    11.02B

  • Enterprise Value

    14.81B

  • Trailing P/E

    15.56

  • Forward P/E

    15.41

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.63

  • Price/Book (mrq)

    1.85

  • Enterprise Value/Revenue

    2.18

  • Enterprise Value/EBITDA

    10.02

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    10.49%

  • Return on Assets (ttm)

    3.61%

  • Return on Equity (ttm)

    12.69%

  • Revenue (ttm)

    6.78B

  • Net Income Avi to Common (ttm)

    711.5M

  • Diluted EPS (ttm)

    1.04

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    262.2M

  • Total Debt/Equity (mrq)

    70.99%

  • Levered Free Cash Flow (ttm)

    769.6M

Research Analysis: AVTR

View More

Company Insights: AVTR

Research Reports: AVTR

View More

People Also Watch